Perioperative management of the patient with immune thrombocytopenic Purpura de Novo and the thrombocytopenia of antiphospholipid antibody syndrome

Perioperative Management of Patients with Rheumatic Disease

Volumn , Issue , 2013, Pages 129-135

  Bobba, Raja S ^a   Crowther, Mark A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Antiphospholipid syndrome; Immune thrombocytopenic purpura; Thrombocytopenia

Indexed keywords

EID: 84901338383     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-2203-7_10     Document Type: Chapter

References (25)

1. Blanchette V, Freedman J, Garvey B. Management of chronic immune thrombocytopenic purpura in children and adults. Semin Hematol. 1998;35(1 Suppl 1):36-51.
2. Bromberg ME. Immune thrombocytopenic purpura- the changing therapeutic landscape. N Engl J Med. 2006;355(16):1643-5.
3. Psaila B, Bussel JB. Immune thrombocytopenic purpura. Hematol Oncol Clin North Am. 2007;21(4): 743-59. vii.
4. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006;4(11):2377-83.
5. Zeller B, Helgestad J, Hellebostad M, et al. Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration. Pediatr Hematol Oncol. 2000;17(7):551-8.
6. Schoonen WM, Kucera G, Coalson J, et al. Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol. 2009;145(2):235-44.
7. Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46(1 Suppl 2):S2-14.
8. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168-86.
9. Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr. L, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190-207.
10. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, de finitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386-93.
11. Chia WK, Blanchette V, Mody M, Wright JF, Freedman J. Characterization of HIV-1-speci fic antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients. Br J Haematol. 1998;103(4):1014-22.
12. Mantadakis E, Farmaki E, Buchanan GR. Thrombocytopenic purpura after measles-mumpsrubella vaccination: a systematic review of the literature and guidance for management. J Pediatr. 2010;156(4):623-8.
13. Arnold DM, Bernotas A, Nazi I, et al. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica. 2009;94(6):850-6.
14. British Society of Haematology. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120(4):574-96.
15. Kuwana M, Okazaki Y, Satoh T, Asahi A, Kajihara M, Ikeda Y. Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura. Am J Med. 2005;118(9):1026-33.
16. Arkfeld DG, Weitz IC. Immune thrombocytopenia in patients with connective tissue disorders and the antiphospholipid antibody syndrome. Hematol Oncol Clin North Am. 2009;23(6):1239-49.
17. Stasi R, Amadori S, Osborn J, Newland AC, Provan D. Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia. PLoS Med. 2006;3(3):e24.
18. Delaitre B, Blezel E, Samama G, et al. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Surg Laparosc Endosc. 2002;12(6):412-9.
19. Shaw M, Mandell BF. Perioperative management of selected problems in patients with rheumatic diseases. Rheum Dis Clin North Am. 1999;25(3): 623-38, ix.
20. Arnold DM, Kelton JG. Current options for the treatment of idiopathic thrombocytopenic purpura. Semin Hematol. 2007;44(4 Suppl 5):S12-23.
21. Reff ME, Carner K, Chambers KS, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood. 1994;83(2): 435-45.
22. Andemariam B, Bussel J. New therapies for immune thrombocytopenic purpura. Curr Opin Hematol. 2007;14(5):427-31.
23. Schilling RF. Estimating the risk for sepsis after splenectomy in hereditary spherocytosis. Ann Intern Med. 1995;122(3):187-8.
24. Kuter DJ. Biology and chemistry of thrombopoietic agents. Semin Hematol. 2010;47(3):243-8.
25. Newland A. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura. Semin Hematol. 2007;44(4 Suppl 5):S35-45.